SIREN : 832291280
PHYLAXIS is a French company founded 8 years ago, specialized in the sector Activités des sièges sociaux. Based in TOULOUSE (31100), this company of category PME shows in 2022 a revenue of 427 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 427 200 € | 506 000 € | 438 799 € | 533 782 € |
| Net income | -70 686 € | -931 509 € | -75 888 € | 13 753 € |
| EBITDA | -4 864 € | 25 636 € | -64 355 € | 29 686 € |
| Net margin | -16.5% | -184.1% | -17.3% | 2.6% |
In 2022, PHYLAXIS achieves revenue of 427 k€. Revenue is declining over the period 2019-2022 (CAGR: -7.2%). Significant drop of -16% vs 2021. After deducting consumption (0 €), gross margin stands at 427 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -5 k€, representing -1.1% of revenue. Warning negative scissor effect: despite revenue change (-16%), EBITDA varies by -119%, reducing margin by 6.2 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -71 k€ (-16.5% of revenue), which will impact equity.
427 200 €
427 200 €
-4 864 €
-57 776 €
-70 686 €
-1.1%
The debt ratio (= Financial debt / Equity x 100) stands at -67%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -475%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
-66.506%
-474.849%
-3.315%
-40.268
40.3%
In 2022, the debt ratio of PHYLAXIS (-66.51) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2022, the financial autonomy of PHYLAXIS (-474.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2022, the repayment capacity of PHYLAXIS (-40.27) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 32.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
32.973
-189.227
In 2022, the liquidity ratio of PHYLAXIS (32.97) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2022, the interest coverage of PHYLAXIS (-189.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 127 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 100 days. The company must finance 27 days of gap between collections and payments. WCR is negative (-241 days): operations structurally generate cash. Notable WCR improvement over the period (-3157%), freeing up cash.
-286 010 €
127 j
100 j
0 j
-241 j
Based on 107 transactions of similar company sales in 2022, the value of PHYLAXIS is estimated at 276 074 € (range 67 148€ - 495 401€). The price/revenue ratio is 0.65x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 107 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PHYLAXIS with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of PHYLAXIS in 2022 is 427 k€.
PHYLAXIS recorded a net loss in 2022.
The headquarters of PHYLAXIS is located in TOULOUSE (31100), in the department Haute-Garonne.
The tax return of PHYLAXIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PHYLAXIS operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.